The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Open accessAbstract
Non-alcoholic fatty liver disease and its downstream sequelae, hepatic insulin resistance and type 2 diabetes, are rapidly growing epidemics, which lead to increased morbidity and mortality rates, and soaring health-care costs. Developing interventions requires a comprehensive understanding of the mechanisms by which excess hepatic lipid develops and causes hepatic insulin resistance and type 2 diabetes. Proposed mechanisms implicate various lipid species, inflammatory signalling and other cellular modifications. Studies in mice and humans have elucidated a key role for hepatic diacylglycerol activation of protein kinase Cε in triggering hepatic insulin resistance. Therapeutic approaches based on this mechanism could alleviate the related epidemics of non-alcoholic fatty liver disease and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationMechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Self-citationObesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationDirect Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
Franke, T. F., Kaplan, D. R., Cantley, L. C., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,460
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Self-citationFatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Self-citationFullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Self-citationTissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Self-citationSunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672
Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647
Self-citationHyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP
Lin, J., Yang, R., Tarr, P. T., Wu, P.-H., Handschin, C., Li, S., Yang, W., Pei, L., Uldry, M., Tontonoz, P., et al. (2005) · Cell · doi:10.1016/j.cell.2004.11.043 · Cited by 625
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585
Self-citationDutchak, P. A., Katafuchi, T., Bookout, A. L., Choi, J. H., Yu, R. T., Mangelsdorf, D. J., & Kliewer, S. A. (2012) · Cell · doi:10.1016/j.cell.2011.11.062 · Cited by 537
Tolman, K. G., Fonseca, V., Dalpiaz, A., & Tan, M. H. (2007) · Diabetes Care · doi:10.2337/dc06-1539 · Cited by 525
Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver
Monetti, M., Levin, M. C., Watt, M. J., Sajan, M. P., Marmor, S., Hubbard, B. K., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.005 · Cited by 511
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497
Self-citationDas, K., Das, K., Mukherjee, P. S., Ghosh, A., Ghosh, S., Mridha, A. R., Dhibar, T., Bhattacharya, B., Bhattacharya, D., Manna, B., et al. (2010) · Hepatology · doi:10.1002/hep.23567 · Cited by 469
Insulin signaling meets mitochondria in metabolism
Cheng, Z., Tseng, Y., & White, M. F. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.005 · Cited by 449
Savage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8456 · Cited by 443
Self-citationLong–Term Outcomes of Cirrhosis in Nonalcoholic Steatohepatitis Compared With Hepatitis C
Hui, J. M., Kench, J. G., Chitturi, S., Sud, A., Farrell, G. C., Byth, K., Hall, P., Khan, M., & George, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50320 · Cited by 437
Diraison, F., Moulin, P., & Beylot, M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70061-7 · Cited by 435
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428
Self-citationBenhamed, F., Denechaud, P.-D., Lemoine, M., Robichon, C., Moldes, M., Bertrand-Michel, J., Ratziu, V., Serfaty, L., Housset, C., Capeau, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci41636 · Cited by 408
Satapati, S., Sunny, N. E., Kucejova, B., Fu, X., He, T. T., Méndez-Lucas, A., Shelton, J. M., Perales, J. C., Browning, J. D., & Burgess, S. C. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m023382 · Cited by 407
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
Fan, J.-G., Zhu, J., Li, X.-J., Chen, L., Li, L., Dai, F., Li, F., & Chen, S.-Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.042 · Cited by 404
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
Petersen, K. F., Dufour, S., Feng, J., Befroy, D., Dziura, J., Man, C. D., Cobelli, C., & Shulman, G. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608537103 · Cited by 403
Self-citationAmarapurkar, D. N., Hashimoto, E., Lesmana, L. A., Sollano, J. D., Chen, P., Goh, K., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05042.x · Cited by 395
Choi, C. S., Savage, D. B., Kulkarni, A., Yu, X. X., Liu, Z.-X., Morino, K., Kim, S., Distefano, A., Samuel, V. T., Neschen, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704213200 · Cited by 383
Self-citationHepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Sun, Z., Miller, R. A., Patel, R. T., Chen, J., Dhir, R., Wang, H., Zhang, D., Graham, M. J., Unterman, T. G., Shulman, G. I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2744 · Cited by 335
Self-citationAdiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase
Kumari, M., Schoiswohl, G., Chitraju, C., Paar, M., Cornaciu, I., Rangrez, A. Y., Wongsiriroj, N., Nagy, H. M., Ivanova, P. T., Scott, S. A., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.008 · Cited by 316
Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy
Gandotra, S., Le Dour, C., Bottomley, W., Cervera, P., Giral, P., Reznik, Y., Charpentier, G., Auclair, M., Delépine, M., Barroso, I., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007487 · Cited by 310
Weight Regain in U.S. Adults Who Experienced Substantial Weight Loss, 1999–2002
Weiss, E. C., Galuska, D. A., Kettel Khan, L., Gillespie, C., & Serdula, M. K. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.02.040 · Cited by 307
Yu, X. X., Murray, S. F., Pandey, S. K., Booten, S. L., Bao, D., Song, X., Kelly, S., Chen, S., McKay, R., Monia, B. P., et al. (2005) · Hepatology · doi:10.1002/hep.20783 · Cited by 301
Liver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Zhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707060104 · Cited by 291
Self-citationNeschen, S., Morino, K., Hammond, L. E., Zhang, D., Liu, Z.-X., Romanelli, A. J., Cline, G. W., Pongratz, R. L., Zhang, X.-M., Choi, C. S., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.006 · Cited by 261
Self-citationJaworski, K., Ahmadian, M., Duncan, R. E., Sarkadi-Nagy, E., Varady, K. A., Hellerstein, M. K., Lee, H.-Y., Samuel, V. T., Shulman, G. I., Kim, K.-H., et al. (2009) · Nature Medicine · doi:10.1038/nm.1904 · Cited by 260
Self-citationLipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ
Wang, F., Mullican, S. E., DiSpirito, J. R., Peed, L. C., & Lazar, M. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314863110 · Cited by 255
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
Petersen, K. F., Laurent, D., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1998) · Journal of Clinical Investigation · doi:10.1172/jci579 · Cited by 237
Self-citationNeschen, S., Morino, K., Dong, J., Wang-Fischer, Y., Cline, G. W., Romanelli, A. J., Rossbacher, J. C., Moore, I. K., Regittnig, W., Munoz, D. S., et al. (2007) · Diabetes · doi:10.2337/db06-1206 · Cited by 233
Self-citationPerry, R. J., Kim, T., Zhang, X.-M., Lee, H.-Y., Pesta, D., Popov, V. B., Zhang, D., Rahimi, Y., Jurczak, M. J., Cline, G. W., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.004 · Cited by 230
Self-citationCellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
Camporez, J. P. G., Jornayvaz, F. R., Petersen, M. C., Pesta, D., Guigni, B. A., Serr, J., Zhang, D., Kahn, M., Samuel, V. T., Jurczak, M. J., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1191 · Cited by 228
Self-citationIntrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Magkos, F., Su, X., Bradley, D., Fabbrini, E., Conte, C., Eagon, J. C., Varela, J. E., Brunt, E. M., Patterson, B. W., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.003 · Cited by 224
Birkenfeld, A. L., Lee, H.-Y., Guebre-Egziabher, F., Alves, T. C., Jurczak, M. J., Jornayvaz, F. R., Zhang, D., Hsiao, J. J., Martin-Montalvo, A., Fischer-Rosinsky, A., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.009 · Cited by 215
Self-citationLiver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M. (2011) · Diabetes Care · doi:10.2337/dc10-1076 · Cited by 212
Jacobs, R. L., Zhao, Y., Koonen, D. P. Y., Sletten, T., Su, B., Lingrell, S., Cao, G., Peake, D. A., Kuo, M.-S., Proctor, S. D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108514 · Cited by 211
Jornayvaz, F. R., Jurczak, M. J., Lee, H.-Y., Birkenfeld, A. L., Frederick, D. W., Zhang, D., Zhang, X.-M., Samuel, V. T., & Shulman, G. I. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2010 · Cited by 211
Self-citationThe Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance
Farese, R. V., Zechner, R., Newgard, C. B., & Walther, T. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.004 · Cited by 209
Abnormal Hepatic Energy Homeostasis in Type 2 Diabetes†
Szendroedi, J., Chmelik, M., Schmid, A. I., Nowotny, P., Brehm, A., Krssak, M., Moser, E., & Roden, M. (2009) · Hepatology · doi:10.1002/hep.23093 · Cited by 204
Nagai, Y., Yonemitsu, S., Erion, D. M., Iwasaki, T., Stark, R., Weismann, D., Dong, J., Zhang, D., Jurczak, M. J., Löffler, M. G., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.011 · Cited by 203
Self-citationGlucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
Kim, J. K., Zisman, A., Fillmore, J. J., Peroni, O. D., Kotani, K., Perret, P., Zong, H., Dong, J., Kahn, C. R., Kahn, B. B., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10294 · Cited by 202
Self-citationRabøl, R., Petersen, K. F., Dufour, S., Flannery, C., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110105108 · Cited by 196
Self-citationRelationship Between Body Fat Mass and Free Fatty Acid Kinetics in Men and Women
Mittendorfer, B., Magkos, F., Fabbrini, E., Mohammed, B. S., & Klein, S. (2009) · Obesity · doi:10.1038/oby.2009.224 · Cited by 192
Camporez, J. P. G., Jornayvaz, F. R., Lee, H.-Y., Kanda, S., Guigni, B. A., Kahn, M., Samuel, V. T., Carvalho, C. R. O., Petersen, K. F., Jurczak, M. J., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1989 · Cited by 192
Self-citationBrown, J. M., Betters, J. L., Lord, C. C., Ma, Y., Han, X., Yang, K., Alger, H. M., Melchior, J., Sawyer, J. K., Shah, R., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m010256 · Cited by 170
Self-citationLipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
Chavez, J. A., & Summers, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.015 · Cited by 169
Doege, H., Grimm, D., Falcon, A., Tsang, B., Storm, T. A., Xu, H., Ortegon, A. M., Kazantzis, M., Kay, M. A., & Stahl, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803510200 · Cited by 169
Flannery, C., Dufour, S., Rabøl, R., Shulman, G. I., & Petersen, K. F. (2012) · Diabetes · doi:10.2337/db12-0206 · Cited by 168
Self-citationHepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
Jornayvaz, F. R., Birkenfeld, A. L., Jurczak, M. J., Kanda, S., Guigni, B. A., Jiang, D. C., Zhang, D., Lee, H.-Y., Samuel, V. T., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103451108 · Cited by 164
Self-citationThe prevalence of weight loss maintenance among American adults
McGuire, M., Wing, R., & Hill, J. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801075 · Cited by 164
Dissociating fatty liver and diabetes
Sun, Z., & Lazar, M. A. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.005 · Cited by 163
The “Obese Insulin-Sensitive” Adolescent: Importance of Adiponectin and Lipid Partitioning
Weiss, R., Taksali, S. E., Dufour, S., Yeckel, C. W., Papademetris, X., Cline, G., Tamborlane, W. V., Dziura, J., Shulman, G. I., & Caprio, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2305 · Cited by 161
Self-citationRuiz, R., Jideonwo, V., Ahn, M., Surendran, S., Tagliabracci, V. S., Hou, Y., Gamble, A., Kerner, J., Irimia-Dominguez, J. M., Puchowicz, M. A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541110 · Cited by 161
Cantley, J. L., Yoshimura, T., Camporez, J. P. G., Zhang, D., Jornayvaz, F. R., Kumashiro, N., Guebre-Egziabher, F., Jurczak, M. J., Kahn, M., Guigni, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219456110 · Cited by 161
Self-citationThe Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2
Hanke, S., & Mann, M. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800407-mcp200 · Cited by 159
Dries, D. R., Gallegos, L. L., & Newton, A. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600268200 · Cited by 159
Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans
Bergman, B. C., Hunerdosse, D. M., Kerege, A., Playdon, M. C., & Perreault, L. (2012) · Diabetologia · doi:10.1007/s00125-011-2419-7 · Cited by 158
Smits, M. M., Ioannou, G. N., Boyko, E. J., & Utzschneider, K. M. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12106 · Cited by 150
Lee, H., Birkenfeld, A. L., Jornayvaz, F. R., Jurczak, M. J., Kanda, S., Popov, V., Frederick, D. W., Zhang, D., Guigni, B. A., Bharadwaj, K. G., et al. (2011) · Hepatology · doi:10.1002/hep.24571 · Cited by 136
Self-citationNagle, C. A., An, J., Shiota, M., Torres, T. P., Cline, G. W., Liu, Z., Wang, S., Catlin, R. L., Shulman, G. I., Newgard, C. B., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611550200 · Cited by 136
Self-citationRosiglitazone Improves Downstream Insulin Receptor Signaling in Type 2 Diabetic Patients
Miyazaki, Y., He, H., Mandarino, L. J., & DeFronzo, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1943 · Cited by 135
Simha, V., Szczepaniak, L. S., Wagner, A. J., DePaoli, A. M., & Garg, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.30 · Cited by 121
Dissociation betweenAPOC3variants, hepatic triglyceride content and insulin resistance
Kozlitina, J., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2010) · Hepatology · doi:10.1002/hep.24072 · Cited by 121
Zhang, C., Chen, X., Zhu, R.-M., Zhang, Y., Yu, T., Wang, H., Zhao, H. J., Zhao, M., Ji, Y., Chen, Y., et al. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.06.002 · Cited by 118
Petersen, K. F., Dufour, S., Morino, K., Yoo, P. S., Cline, G. W., & Shulman, G. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205675109 · Cited by 114
Self-citationTriglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Mingrone, G., Henriksen, F. L., Greco, A., Krogh, L., Capristo, E., Gastaldelli, A., Castagneto, M., Ferrannini, E., Gasbarrini, A., & Beck‐Nielsen, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1258 · Cited by 112
Lin, Y., Chang, P., Chang, M., & Ni, Y. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.079749 · Cited by 110
Prieur, X., Dollet, L., Takahashi, M., Nemani, M., Pillot, B., May, C. L., Mounier, C., Takigawa-Imamura, H., Zélénika, D., Matsuda, F., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2926-9 · Cited by 99
Befroy, D. E., Perry, R. J., Jain, N., Dufour, S., Cline, G. W., Trimmer, J. K., Brosnan, J. M., Rothman, D. L., Petersen, K. F., & Shulman, G. I. (2013) · Nature Medicine · doi:10.1038/nm.3415 · Cited by 99
Self-citationAS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues
Wang, H. Y., Ducommun, S., Quan, C., Xie, B., Li, M., Wasserman, D. H., Sakamoto, K., MacKintosh, C., & Chen, S. (2012) · Biochemical Journal · doi:10.1042/bj20120702 · Cited by 97
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
Bilz, S., Samuel, V. T., Morino, K., Savage, D. B., Choi, C. S., & Shulman, G. I. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00355.2005 · Cited by 97
Self-citationKim, J. K., Fillmore, J. J., Gavrilova, O., Chao, L. C., Higashimori, T., Choi, H., Kim, H., Yu, C., Chen, Y., Qu, X., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1311 · Cited by 96
Self-citationCao, H., Maeda, K., Görgün, C. Z., Kim, H., Park, S., Shulman, G. I., Kim, J. K., & Hotamışlıgil, G. S. (2006) · Diabetes · doi:10.2337/db05-1496 · Cited by 92
Self-citationKumashiro, N., Yoshimura, T., Cantley, J. L., Majumdar, S. K., Guebre‐Egziabher, F., Kursawe, R., Vatner, D. F., Fat, I., Kahn, M., Erion, D. M., et al. (2012) · Hepatology · doi:10.1002/hep.26170 · Cited by 89
Self-citationRegulation of the structure and activity of pyruvate carboxylase by acetyl CoA
Adina-Zada, A., Zeczycki, T. N., & Attwood, P. V. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.11.015 · Cited by 84
Kantartzis, K., Machicao, F. E., Machann, J., Schick, F., Fritsche, A., Häring, H., & Stefan, N. (2008) · Clinical Science · doi:10.1042/cs20080306 · Cited by 83
Raddatz, K., Turner, N. A., Frangioudakis, G., Liao, B. M., Pedersen, D. J., Cantley, J., Wilks, D. L., Preston, E., Hegarty, B. D., Leitges, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2073-0 · Cited by 79
Jornayvaz, F. R., Lee, H., Jurczak, M. J., Alves, T. C., Guebre‐Egziabher, F., Guigni, B. A., Zhang, D., Samuel, V. T., Silva, J. E., & Shulman, G. I. (2011) · Endocrinology · doi:10.1210/en.2011-1793 · Cited by 78
Self-citationHaufe, S., Haas, V. K., Utz, W., Birkenfeld, A. L., Jeran, S., Böhnke, J., Mähler, A., Luft, F. C., Schulz‐Menger, J., Boschmann, M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0102 · Cited by 78
Morán‐Ramos, S., Ávila-Nava, A., Tovar, A. R., Pedraza‐Chaverrí, J., López‐Romero, P., & Torres, N. (2012) · Journal of Nutrition · doi:10.3945/jn.112.165563 · Cited by 77
Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice
Singhal, N. S., Patel, R. T., Qi, Y., Lee, Y.-S., & Ahima, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00577.2007 · Cited by 76
Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis
Niebergall, L. J., Jacobs, R. L., Chaba, T., & Vance, D. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.021 · Cited by 74
Shindo, N., Fujisawa, T., Sugimoto, K., Nojima, K., Fukai, A., Yoshikawa, Y., Wang, X., Yasuda, O., Ikegami, H., & Rakugi, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.033 · Cited by 72
Verrijken, A., Beckers, S., Francque, S., Hilden, H., Caron, S., Zegers, D., Ruppert, M., Hubens, G., Marck, E. V., Michielsen, P. P., et al. (2013) · Obesity · doi:10.1002/oby.20366 · Cited by 71
Houten, S. M., Herrema, H., Brinke, H. T., Denis, S. W., Ruiter, J. P. N., van Dijk, T. H., Argmann, C., Ottenhoff, R., Müller, M. M., Groen, A. K., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt382 · Cited by 71
Cortés, V., Cautivo, K. M., Rong, S., Garg, A., Horton, J. D., & Agarwal, A. K. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m045799 · Cited by 65
Auinger, A., Valenti, L. V. C., Pfeuffer, M., Helwig, U., Herrmann, J. E., Fracanzani, A. L., Dongiovanni, P., Fargion, S. R., Schrezenmeir, J., & Rubin, D. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1267186 · Cited by 53
Savage, D. B., Murgatroyd, P. R., Chatterjee, V. K., & O’Rahilly, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1494 · Cited by 47
Pardina, E., Baena‐Fustegueras, J. A., Catalán, R., Galard, R., Lecube, A., Fort, J. M., Allende, H., Vargas, V., & Peinado‐Onsurbe, J. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9739-9 · Cited by 43
Xu, E., Forest, M., Schwab, M. G., Avramoglu, R. K., St-Amand, E., Caron, A. Z., Bellmann, K., Shum, M., Voisin, G., Paquet, M., et al. (2013) · Hepatology · doi:10.1002/hep.26957 · Cited by 43
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
Peter, A., Kantartzis, K., Machicao, F. E., Machann, J., Wagner, S., Templin, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.154 · Cited by 42
Allosteric regulation of the biotin-dependent enzyme pyruvate carboxylase by acetyl-CoA
Adina-Zada, A., Zeczycki, T. N., Maurice, M. S., Jitrapakdee, S., Cleland, W. W., & Attwood, P. V. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120041 · Cited by 42
Asai, A., Chou, P. M., Bu, H., Wang, X., Rao, M. S., Jiang, A., DiDonato, C. J., & Tan, X. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00291.2013 · Cited by 40
Brown, W. H., Gillum, M. P., Lee, H., Camporez, J. P., Zhang, X., Jeong, J. K., Alves, T. C., Erion, D. M., Guigni, B. A., Kahn, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212887109 · Cited by 35
Self-citationFunke, A., Schreurs, M., Aparicio-Vergara, M., Sheedfar, F., Gruben, N., Kloosterhuis, N., Shiri‐Sverdlov, R., Groen, A. K., van de Sluis, B., Hofker, M. H., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.074 · Cited by 26
Research works printed but not linked: 2
- Pilkis, S. J., el-Maghrabi, M. R. & Claus, T. H. Fructose-2,6-bisphosphate in control of hepatic gluconeogenesis. From metabolites to molecular genetics. Diabetes Care 13, 582–599 (1990). · DOI
- Delarue, J., Normand, S., Couet, C. & Pachiaudi, C. Effects of free fatty acids on the metabolic response to oral fructose in lean healthy humans. Int. J. Obes. Relat. Metab. Disord. 20, 130–136 (1996).
Cited by
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Self-citationDeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Self-citationAdipose tissue dysfunction as determinant of obesity-associated metabolic complications
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F., & Miele, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092358 · Cited by 1,575
Metadata
- Authors
- Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I.
- Venue
- Nature
- Published
- 2014-06
- Volume
- 510
- Issue
- 7503
- Pages
- 84-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1973939264
- Cited by
- 1,136
- References
- 119
- FWCI
- 70.56
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.